A Clinical Study to establish how quickly Oats and Breakfast Cereals raise blood sugar levels in healthy individuals.

Estimation of Glycemic Index of Oats and breakfast cereal â?? An open label, interventional, comparative, prospective, cross over type, clinical study - NIL

Status

Recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/107786

Enrollment

Registered

2026-04-07

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: 1.Reference food/glucose powder (25 g available CHO) 2.Product T1: Plain Oats in water (25 g available CHO) 3.Product T2: Plain Oats in milk (25 g available CHO) 4.Product T3: Multigrai

Eligibility

Inclusion criteria

Inclusion criteria: 1.Healthy non diabetic Male and female participants 2. Participants having BMI 18.5 to 22.9 kg per meter square 3. Participants willing to follow the procedures as per the study protocol and voluntarily signing informed consent form

Exclusion criteria

Exclusion criteria: 1. Any history or presence of clinical relevance of cardiovascular, neurological, musculoskeletal, haematological, hepatic, gastrointestinal, renal, pulmonary, endocrinological, metabolism or psychiatric disease, any type of porphyria. 2. Presence or history of malabsorption or any gastrointestinal surgery except appendectomy or except herniotomy. 3. Participants who have participated to any drug research within the last one month before the first drug administration. 4. Participants suspected to have a high probability of non-compliance to the study procedure and or completion of the study according to the investigators judgement. 5. History of allergic response to Oats, fortified oats, referred food or breakfast cereal with corn millet flakes, seeds, nuts etc. 6. Participants who have any chronic disease which might interfere with absorption, distribution, metabolism or excretion of the drug. 7. History of drug and alcohol abuse. 8. History of difficulty in swallowing. 9. Pregnant and Lactating females 10. Participants having any medical or surgical condition that would require immediate medical or surgical intervention at the time of screening 11. Participants having immune compromised status like HIV, Hepatitis, Tuberculosis and Cancer etc. 12. Other conditions, which in the opinion of the investigators makes the patient unsuitable for enrolment or could interfere in adherence to of the study protocol

Design outcomes

Primary

Measure	Time frame
Comparative assessment of Glycemic index of the test productsTimepoint: Baseline (O mins), 15 mins, 30 mins, 45 mins, 60 mins, 90 mins and 120 mins	—

Secondary

Measure	Time frame
Adverse events, adverse drug reactions including vitalsTimepoint: Baseline (O mins), 15 mins, 30 mins, 45 mins, 60 mins, 90 mins and 120 mins	—

Countries

India

Contacts

Public ContactDr Sanjay Tamoli

Target Institute of Medical Education and Research Pvt. Ltd

targetinstitute@yahoo.com9322522252

Outcome results